ONCOLOGY PHARMA INC (ONPH)
Institutional ownership reported to the SEC as of Q2 2026, across 12 quarters.
1
Reporting holders
$0
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| HANTZ FINANCIAL SERVICES, INC. | $0 | 121 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $0 | 121 | 1 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $32 | 400 | 1 | 0 | 0 | 0.0% |
| Q3 2023 | 1 | $63 | 974 | 0 | 0 | 0 | 0.0% |
| Q2 2023 | 1 | $312 | 974 | 1 | 0 | 0 | 0.0% |
| Q1 2023 | 1 | $2.6K | 14,250 | 1 | 0 | 0 | 0.0% |
| Q4 2022 | 1 | $330 | 974 | 0 | 0 | 0 | 0.0% |
| Q3 2022 | 1 | $7.9M | 17,250 | 0 | 0 | 1 | 0.0% |
| Q2 2022 | 2 | $110.6K | 51,701 | 1 | 1 | 0 | 0.0% |
| Q1 2022 | 2 | $12.0K | 4,000 | 1 | 0 | 0 | 0.0% |
| Q4 2021 | 1 | $4.0K | 1,000 | 0 | 0 | 1 | 0.0% |
| Q3 2021 | 1 | $12.0K | 1,050 | 0 | 1 | 0 | 0.0% |
| Q2 2021 | 1 | $1.0K | 50 | 1 | 0 | 0 | 0.0% |